フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE...
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF...
EINDHOVEN, the Netherlands, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System Grant will...
EINDHOVEN, The Netherlands, Aug. 27, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update Company to provide more detailed commercial plans for its ARC-EX...
Company expects to commercialize the investigational ARC-EX® System in Q4 2024 and has commenced launch...
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights Company expects to commercialize the...
ONWARD® Medical Publishes Annual Sustainability Summary Company strengthens sustainability practices prior to commercializationEINDHOVEN, the...
EINDHOVEN, the Netherlands, July 17, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal...
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy Framework to determine stimulation parameters...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約